1
|
Sharpe L, Turner J, Fardell JE, Thewes B, Smith AB, Gilchrist J, Beith J, Girgis A, Tesson S, Day S, Grunewald K, Butow P. Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy. J Cancer Surviv 2019; 13:695-702. [PMID: 31347010 DOI: 10.1007/s11764-019-00788-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2018] [Accepted: 07/05/2019] [Indexed: 12/16/2022]
Abstract
PURPOSE ConquerFear is an efficacious intervention for fear of cancer recurrence (FCR) that demonstrated greater improvements than an attention control (relaxation training) in a randomized controlled trial. This study aimed to determine mediators and moderators of the relative treatment efficacy of ConquerFear versus relaxation. METHODS One hundred and fifty-two cancer survivors completed 5 therapy sessions and outcome measures before and after intervention and at 6 months' follow-up. We examined theoretically relevant variables as potential mediators and moderators of treatment outcome. We hypothesized that metacognitions and intrusions would moderate and mediate the relationship between treatment group and FCR level at follow-up. RESULTS Only total FCR score at baseline moderated treatment outcome. Participants with higher levels of FCR benefited more from ConquerFear relative to relaxation on the primary outcome. Changes in metacognitions and intrusive thoughts about cancer during treatment partially mediated the relationship between treatment group and FCR. CONCLUSIONS These results show that ConquerFear is relatively more effective than relaxation for those with overall higher levels of FCR. The mediation analyses confirmed that the most likely mechanism of treatment efficacy was the reduction in unhelpful metacognitions and intrusive thoughts during treatment, consistent with the theoretical framework underpinning ConquerFear. IMPLICATIONS FOR CANCER SURVIVORS ConquerFear is a brief, effective treatment for FCR in cancer survivors with early-stage disease. The treatment works by reducing intrusive thoughts about cancer and changing beliefs about worry and is particularly helpful for people with moderate to severe FCR.
Collapse
Affiliation(s)
- Louise Sharpe
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia.
| | - J Turner
- Mental Health Centre, Faculty of Medicine, University of Queensland, Saint Lucia, Australia
| | - J E Fardell
- Kids Cancer Centre, Sydney Children's Hospital and School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Saint Lucia, Australia
| | - B Thewes
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia.,Department Medical Psychology, Radboud University Medical Centre, Nijmegen, Netherlands
| | - A B Smith
- Centre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia
| | - J Gilchrist
- Crown Princess Mary Cancer Centre, Breast Cancer Institute, Westmead Hospital, Westmead, Australia
| | - J Beith
- Psycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Camperdown, Australia.,Department of Medical Oncology, Chris O'Brien Lifehouse, Missenden Rd., Camperdown, Australia
| | - A Girgis
- Centre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia
| | - S Tesson
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia
| | - S Day
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia
| | - K Grunewald
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia
| | - P Butow
- School of Psychology, University of Sydney, Brennan MacCallum (A18), Camperdown, NSW, 2006, Australia.,Psycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Camperdown, Australia
| | | |
Collapse
|
2
|
Sundaresan P, Ager B, Turner S, Costa D, Kneebone A, Pearse M, Woo H, Tesson S, Juraskova I, Butow P. A Randomized Controlled Trial Evaluating the Utility of a Patient Decision Aid to Improve Clinical Trial (RAVES 08.03) Related Decision-Making. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Sundaresan P, Ager B, Butow P, Tesson S, Kneebone A, Costa D, Woo H, Pearse M, Juraskova I, Turner S. PV-0050: A randomised controlled study of decision aids to improve clinical trial decisions & recruitment. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30494-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Porzio F, Cuierrier É, Wespiser C, Tesson S, Underhill RS, Soldera A. Mechanical equilibrium, a prerequisite to unveil auxetic properties in molecular compounds. Molecular Simulation 2016. [DOI: 10.1080/08927022.2016.1241397] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- F. Porzio
- Centre Québécois sur les Matériaux Fonctionnels (CQMF), Département de Chimie, Université de Sherbrooke, Sherbrooke, Canada
| | - É. Cuierrier
- Centre Québécois sur les Matériaux Fonctionnels (CQMF), Département de Chimie, Université de Sherbrooke, Sherbrooke, Canada
| | - C. Wespiser
- Centre Québécois sur les Matériaux Fonctionnels (CQMF), Département de Chimie, Université de Sherbrooke, Sherbrooke, Canada
| | - S. Tesson
- Centre Québécois sur les Matériaux Fonctionnels (CQMF), Département de Chimie, Université de Sherbrooke, Sherbrooke, Canada
| | - R. S. Underhill
- Defence R&D Canada, Atlantic Research Centre, Dartmouth, Canada
| | - A. Soldera
- Centre Québécois sur les Matériaux Fonctionnels (CQMF), Département de Chimie, Université de Sherbrooke, Sherbrooke, Canada
| |
Collapse
|
5
|
Sundaresan P, Tesson S, Ager B, Butow P, Juraskova I, Costa D, Kneebone A, Woo H, Pearse M, Turner S. EP-1460: Knowledge, attitudes and decision-making preferences of men considering clinical trial participation. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32710-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|